What does Assembly Biosciences, Inc. do?
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and…
What is Assembly Biosciences, Inc.'s P/E and P/B ratio?
Assembly Biosciences, Inc. has a P/E ratio of 19.5 and a P/B ratio of 1.35.
What is Assembly Biosciences, Inc.'s debt-to-equity ratio?
Assembly Biosciences, Inc. has a debt-to-equity ratio of 0.01.
How much does Assembly Biosciences, Inc. owe compared with what it owns?
Assembly Biosciences, Inc. owes $0.08 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Assembly Biosciences, Inc.'s Positivity rank?
Assembly Biosciences, Inc. is ranked #708 of 6,774 companies globally and #115 of 4,000 in United States on PositoAI, with a Positivity Score of 23,850.
Does Assembly Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Assembly Biosciences, Inc..
Where can I read the latest news about Assembly Biosciences, Inc.?
Recent headlines about Assembly Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Assembly Biosciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Assembly Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.